Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DUPILUMAB Cause Pulmonary function test decreased? 39 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Pulmonary function test decreased have been filed in association with DUPILUMAB (Dupixent). This represents 0.0% of all adverse event reports for DUPILUMAB.

39
Reports of Pulmonary function test decreased with DUPILUMAB
0.0%
of all DUPILUMAB reports
0
Deaths
6
Hospitalizations

How Dangerous Is Pulmonary function test decreased From DUPILUMAB?

Of the 39 reports, 6 (15.4%) required hospitalization, and 2 (5.1%) were considered life-threatening.

Is Pulmonary function test decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 39 reports have been filed with the FAERS database.

What Other Side Effects Does DUPILUMAB Cause?

Pruritus (44,279) Dermatitis atopic (33,670) Product use in unapproved indication (33,452) Rash (30,895) Injection site pain (27,799) Drug ineffective (23,712) Dry skin (20,239) Eczema (20,020) Product dose omission issue (18,189) Condition aggravated (16,459)

What Other Drugs Cause Pulmonary function test decreased?

IVACAFTOR\LUMACAFTOR (378) ALBUTEROL (325) BUDESONIDE\FORMOTEROL (304) OMALIZUMAB (288) PREDNISONE (275) AZTREONAM LYSINE (252) TIOTROPIUM (223) PIRFENIDONE (207) ELEXACAFTOR\IVACAFTOR\TEZACAFTOR (192) TOBRAMYCIN (190)

Which DUPILUMAB Alternatives Have Lower Pulmonary function test decreased Risk?

DUPILUMAB vs DURAGESIC DUPILUMAB vs DUROGESIC DUPILUMAB vs DUROTEP MT DUPILUMAB vs DURVALUMAB DUPILUMAB vs DUTASTERIDE

Related Pages

DUPILUMAB Full Profile All Pulmonary function test decreased Reports All Drugs Causing Pulmonary function test decreased DUPILUMAB Demographics